Prognostic factors of advanced gastric carcinoma without serosal invasion (pT2 gastric carcinoma)

Hepato-Gastroenterology

Volumn 46, Issue 28, 1999, Pages 2669-2672

  Isozaki, Hiroshi ^a   Fujii, Keizo ^b   Nomura, Eiji ^b   Mabuchi, Hideaki ^b   Nishiguchi, Kanji ^b   Hara, Hítoshi ^b   Tanigawa, Nobuhiko ^b  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Advanced gastric cancer; Depth of invasion; Lymph node metastasis; Macroscopic type; Prognostic factors; pT2

Indexed keywords

ADULT; ARTICLE; CANCER INVASION; CANCER SURGERY; CHEMOTHERAPY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; SEROSA; STATISTICAL ANALYSIS; STOMACH CANCER; STOMACH CARCINOMA; VENOUS CIRCULATION;

FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 0032855231     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Nagata T, Ikeda M, Nakayama F: Changing state of gastric cancer in Japan. Am J Surg 1983; 145:226-233.
2. Mori M, Adachi Y, Nakamura K, Kuroiwa S, Enjoji M, Sugimachi K: Advanced gastric carcinoma simulating early gastric carcinoma. Cancer 1990; 65:1033-1040.
3. International Union Against Cancer UICC): Sobin LH, Wittekind Ch (Eds.). TNM classification of malignant tumours. 5th Edition. New York: John Wiley, 1997; pp. 59-62.
4. Iwanaga T, Koyama H, Furukawa H, Taniguchi H, Wads A, Tateishi R: Mechanisms of late recurrence after radical surgery for gastric carcinoma. Am J Surg 1978; 135:637-640.
5. Koga S, Hamazoe R, Maeta M, Shimizu N, Murakami A, Wakatsuki T: Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 1988; 61:232-237.
6. Baba H, Korenaga D, Okamura T, Saito A, Sugimachi K: Prognostic factors in gastric cancer with serosal invasion. Arch Surg 1989; 124:1061-1064.
7. Maruyama K: The most important prognostic factors for gastric cancer patients. A study using univariate and multivariate analysis. Scand J Gastroenterol 1987; 22(Suppl 133):63-68.
8. Roder JD, Bottcher K, Siewert R, Busch R, Hermanek P, Meyer HJ, the German Gastric Carcinoma Study Group: Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer 1993; 72:2089-2097.
9. Kim JP, Kim YW, Yang HK, Noh DY: Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients. World J Surg 1994; 18:872-878.
10. Maehara Y, Anai H, Moriguchi S, Watanabe A, Tsujitani S, Sugimachi K: Gastric carcinoma invading muscularis propria and macroscopic appearance. Eur J Surg Oncol 1992; 18:131-134.
11. Schmitz-Moormann P, Hermanek P, Himmelmann GW: Morphological predictors of survival in early and advanced gastric carcinoma, J Cancer Res Clin Oncol 1992; 118:296-302.
12. Ichiyoshi Y, Tomada M, Tomisaki S, Oda S, Ohno S, Maehara Y, Sugimachi K: Macroscopic appearance and biological character of gastric cancer invading the muscularis propria. Hepato-Gastroenterology 1996; 43:553-559.
13. Wang JY, Hsieh JS, Huang CJ, Huang YS, Huang TJ: Clinicopathological study of advanced gastric cancer without serosal invasion in young and old patients. J Surg Oncol 1996; 63:36-40.
14. Maehara Y, Oshiro T, Adachi Y, Ohno S, Akazawa K, Sugimachi K: Growth pattern and prognosis of gastric cancer invading the subserosa. J Surg Oncol 1994; 55:203-208.
15. Noguchi Y: Blood vessel invasion in gastric carcinoma. Surgery 1990; 107:140-148.
16. Isozaki H, Okajima K, Fujiwara A, Yasuda M, Kawashima Y, Yamada S, Sakuramoto K, Kubokawa M: Retrospective analysis of the cases died of the recurrent gastric cancer. Jpn J Gastroenterol Surg 1987; 20:2097-2102. (In Japanese)
17. Msika S, Chastang C, Houry S, Lacaine F, Huguier M: Lymph node involvement as the only prognostic factor in curative resected gastric carcinoma: A multivariate analysis. World J Surg 1989; 13:118-128.
18. Shiu MH, Perrotti M, Brennan MF: Adenocarcinoma of the stomach: A multivariate analysis of clinical, pathological and treatment factors. Hepato-Gastroenterology 1989; 36:7-12.
19. Isozaki H, Okajima K, Kawashima Y, Yamada S, Nakata E, Nishimura J, Ichinona T: Prognostic value of the number of metastatic lymph nodes in gastric cancer with radical surgery. J Surg Oncol 1993; 53:247-251.
20. Noguchi M, Miyazaki I.: Prognostic significance and surgical management of lymph node metastasis in gastric cancer. Br J Surg 1996; 83:156-161.
21. Siewert JR, Kestlmeier R, Busch R, Bottcher K, Roder JD, Muller J, Fellbaum C, Hofler H: Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastasis. Br J Surg 1996; 83:1144-1147.
22. de Manzoni G, Verlato G, Guglielmi A, Laterza E, Genna M, Cordiano C: Prognostic significance of lymph node dissection in gastric cancer. Br J Surg 1996; 88:1604-1607.
23. Dent DM, Madden MV, Price SK: Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg 1988; 75:110-112.
24. Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JTM, van Elk P, Obertop H, Gouma DJ, Taat CW, van Lanschot J, Meyer S, de Graaf PW, von Meyerfeldt MF, Tilanus H, van de Velde CJH: Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345:745-748.